Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Randomised Multicentre Study of CAMPATH-1H Versus Basiliximab Induction Treatment and Sirolimus Versus Tacrolimus Maintenance Treatment for the Preservation of Renal Function in Patients Receiving Kidney Transplants

NCT01120028 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT01120028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01120028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Randomised Multicentre Study of CAMPATH-1H Versus Basiliximab Induction Treatment and Sirolimus Versus Tacrolimus Maintenance Treatment for the Preservation of Renal Function in Patients Receiving Kidney Transplants
Lead sponsor
University of Oxford
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2010
Completion date
March 31, 2020
Enrollment
852 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation